Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company, on Wednesday announced the appointment of Todd Baumgartner as Chief Regulatory Officer.
Baumgartner, with over 35 years of experience, will be responsible for heading Applied's global regulatory strategy.
Before joining the company, Baumgartner served as Senior Vice President of Global Regulatory Affairs, Pharmacovigilance, and Biometrics at Ovid Therapeutics.
Tuesday, Applied Therapeutics had closed 4.70% lesser at $0.52 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.